Nova Patents
PL403104A1

Method for preparing a pharmaceutical composition comprising derivatives of 8 - [3-Amino-piperidin-1-yl]-xanthine

Abstract

The invention relates to a process for the preparation of a pharmaceutical composition comprising substituted 8- [3-aminopiperidin-1-yl] xanthine of general formula (I) wherein the substituents R 1 to R 3 are as defined in the claims. The compositions have valuable pharmacological properties, especially the effect of inhibiting the activity of the dipepidyl peptidase-IV (DPP-IV) enzyme.

Term

Term ended

Projected expiry passed 18 August 2023, 3.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

155 members in 42 offices

This recordMember, by publication datePriority claim32 more offices are in the list below

Priority claims10

Priority claims
DocumentOfficeKindDate
10238243GermanyA
10238243GermanyA
10312353GermanyA
10312353GermanyA
102382433–––
103123539–––
DE20021038243–––
DE2002138243–––
DE20031012353–––
DE2003112353–––

Members155

Family members, oldest first
DocumentOfficeKind
CA2496249A1CanadaA1
DE10238243A1GermanyA1
WO2004018468A2World Intellectual Property Organization (WIPO)A2
AU2003253418A1AustraliaA1
UY27946A1UruguayA1
TW200404542ATaiwan Province of ChinaA
WO2004018468A3World Intellectual Property Organization (WIPO)A3
US2004097510A1United States of AmericaA1
DE10312353A1GermanyA1
PE20040897A1PeruA1
NO20050069LNorwayL
NO20130968LNorwayL
NO20140234LNorwayL
MXPA05001684AMexicoA
AR041025A1ArgentinaA1
EP1532149A2European Patent Office (EPO)A2
ECSP055617AEcuadorA
KR20050058375ARepublic of KoreaA
CN1675212AChinaA
EA200500302A1Eurasian Patent Organization (EAPO)A1
PL375342A1PolandA1
JP2006503013AJapanA
HK1081552A1Hong Kong, ChinaA1
HRP20050157A2CroatiaA2
ZA200500087BSouth AfricaB
BR0313648ABrazilA
RS20050137ASerbiaA
NZ538975ANew ZealandA
EA200702022A1Eurasian Patent Organization (EAPO)A1
US7407955B2United States of AmericaB2
EA010303B1Eurasian Patent Organization (EAPO)B1
US2008249089A1United States of AmericaA1
UA84275C2UkraineC2
US2008255159A1United States of AmericaA1
JP2009001565AJapanA
MY137619AMalaysiaA
JP4233524B2JapanB2
JP2009079061AJapanA
KR20090047560ARepublic of KoreaA
EP2058311A2European Patent Office (EPO)A2
EP2060573A2European Patent Office (EPO)A2
SA03240448B1Saudi ArabiaB1
EP2070539A1European Patent Office (EPO)A1
NZ564768ANew ZealandA
CN100522962CChinaC
CN101503408AChinaA
CN101503409AChinaA
TW200944209ATaiwan Province of ChinaA
EP1532149B1European Patent Office (EPO)B1
TWI319320BTaiwan Province of ChinaB
ATE453644T1AustriaT1
DE50312295D1GermanyD1
PT1532149EPortugalE
HK1134076A1Hong Kong, ChinaA1
HK1134077A1Hong Kong, ChinaA1
AU2003253418B2AustraliaB2
AU2010201384A1AustraliaA1
DK1532149T3DenmarkT3
ES2339112T3SpainT3
SI1532149T1SloveniaT1
HRP20090665A2CroatiaA2
EA201001167A1Eurasian Patent Organization (EAPO)A1
IL166964AIsraelA
EP2058311A3European Patent Office (EPO)A3
EP2060573A3European Patent Office (EPO)A3
EP2308878A2European Patent Office (EPO)A2
EP1532149B9European Patent Office (EPO)B9
ME00396BMontenegroB
MEP59708AMontenegroA
EG25011AEgyptA
AR077875A2ArgentinaA2
EP2308878A3European Patent Office (EPO)A3
LTPA2011013I1LithuaniaI1
LU91889I2LuxembourgI2
FR11C0052I1FranceI1
CA2496249CCanadaC
US8119648B2United States of AmericaB2
UA97468C2UkraineC2
EA016166B1Eurasian Patent Organization (EAPO)B1
DE122011100059I1GermanyI1
ECSP12005617AEcuadorA
US8178541B2United States of AmericaB2
KR101150449B1Republic of KoreaB1
KR101111101B1Republic of KoreaB1
JP4971251B2JapanB2
US2012208831A1United States of AmericaA1
JP2012162555AJapanA
RS52142BSerbiaB
RS20120139A2SerbiaA2
FR11C0052I2FranceI2
HRP20050157B1CroatiaB1
TW201304782ATaiwan Province of ChinaA
LU92128I2LuxembourgI2
TWI388325BTaiwan Province of ChinaB
CN102964347AChinaA
CN101503408BChinaB
AU2010201384B2AustraliaB2
AU2013202252A1AustraliaA1
PL403104A1This recordPolandA1
AU2010201384C1AustraliaC1
Showing 100 of 155